Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 23, 1475-1482, September 1, 1963]
© 1963 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugiura, K.
Right arrow Articles by Merker, P. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sugiura, K.
Right arrow Articles by Merker, P. C.

A Mitomycin C-Resistant Jensen Rat Sarcoma: Chemotherapy Studies*

Kanematsu Sugiura and Philip C. Merker1

Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, Sloan-Kettering Division, Graduate School of Medical Sciences, Cornell University, New York, New York

A total of 38 compounds and antibiotics were tested against a mitomycin C-resistant Jensen Rat Sarcoma. Seventeen alkylating agents and two folic acid antagonists, which were effective against the mitomycin C-sensitive Jensen rat sarcoma, were found to be relatively non-inhibitory against the mitomycin C-resistant Jensen rat sarcoma. Nineteen compounds which were inactive or slightly inhibitory against the mitomycin C-sensitive sarcoma were judged to be relatively inactive against the mitomycin C-resistant sarcoma.

* This investigation was supported in part by a grant from the American Cancer Society and in part by contract SA-43-ph-2445, Cancer Chemotherapy National Service Center, National Cancer Institute, National Institutes of Health.

1 Present address: College of Pharmacy, University of Tennessee, Memphis, Tennessee.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1963 by the American Association for Cancer Research.